GT Biopharma, Inc. (GTBP) vs SeaStar Medical Holding Corporation (ICU)
A side-by-side comparison of GT Biopharma, Inc. and SeaStar Medical Holding Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GTBP
GT Biopharma, Inc.
$6.20HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
ICU
SeaStar Medical Holding Corporation
$3.23HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — GTBP vs ICU
growth of $100 · dividends reinvested · last 4yGTBP -99.5% (-74.0%/yr)ICU -99.9% (-80.7%/yr)GTBP compounded faster over this window
GTBP ICU
GTBP vs ICU: by the numbers
- •ICU is the larger company ($9M vs $8M market cap).
- •Both run net losses; GTBP's is the smaller (0.00% vs -795.50% net margin).
Metrics side by side
Valuation
| Metric | GTBP | ICU |
|---|---|---|
| P/S ratio | N/A | 5.35 |
| P/B ratio | 2.19 | 2.13 |
Profitability
| Metric | GTBP | ICU |
|---|---|---|
| Gross margin | 0.00% | 92.64% |
| Operating margin | 0.00% | -986.63% |
| Net margin | 0.00% | -795.50% |
| ROE | -618.74% | -317.20% |
| ROIC | -457.75% | -325.63% |
Growth (annualized)
| Metric | GTBP | ICU |
|---|---|---|
| Total return CAGR (5Y) | -73.13% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.